Acute Leukemia of Ambiguous Lineage

general

A rare subtype of acute leukemia in which the blasts lack sufficient evidence to classify as myeloid or lymphoid, or they have morphologic and/or immunophenotypic characteristics of both myeloid and lymphoid cells. These subtypes account for less than 4% of cases of acute leukemia.

65

Centers

141

Active Trials

$110M

Cancer Funding

Specific Cancer Types(2)

Top Centers for Acute Leukemia of Ambiguous Lineage(65)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
80.6
2
NCI Comprehensive
High-Volume Research Center
78.7
3
NCI Comprehensive
High-Volume Research Center
72.3
471.7
5
NCI Comprehensive
High-Volume Research Center
71.4
6
High-Volume Research Center
71.1
7
NCI Comprehensive
High-Volume Research Center
70.1
8
Active Research Program
69.9
9
NCI Comprehensive
Active Research Program
67.8
10
NCI Comprehensive
Active Research Program
67.8
11
Active Research Program
67.8
12
NCI Comprehensive
Active Research Program
61.7
13
NCI Comprehensive
Active Research Program
61.7
14
NCI Comprehensive
Active Research Program
61.7
15
NCI Comprehensive
Active Research Program
61.7
16
Active Research Program
61.7
17
Active Research Program
61.7
1861.7
19
NCI Comprehensive
Active Research Program
56.6
20
NCI Comprehensive
Active Research Program
56.6
21
NCI Comprehensive
Active Research Program
56.6
22
NCI Clinical
Active Research Program
56.6
23
NCI Comprehensive
Active Research Program
55.8
24
Active Research Program
54.9
25
NCI Comprehensive
Active Research Program
53.6
26
NCI Comprehensive
Active Research Program
53.0
27
NCI Comprehensive
Active Research Program
53.0
28
NCI Comprehensive
Active Research Program
52.3
29
NCI Comprehensive
Active Research Program
51.9
30
NCI Comprehensive
Active Research Program
51.9
31
NCI Comprehensive
Active Research Program
44.6
32
NCI Comprehensive
Active Research Program
44.6
33
NCI Comprehensive
Active Research Program
44.6
34
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
44.6
35
NCI Comprehensive
Active Research Program
44.6
36
NCI Comprehensive
Active Research Program
44.6
37
NCI Clinical
Active Research Program
44.6
38
Active Research Program
44.6
39
Active Research Program
44.6
40
NCI Comprehensive
Active Research Program
44.6
41
NCI Clinical
Active Research Program
44.6
42
NCI Comprehensive
Active Research Program
44.6
43
NCI Comprehensive
Active Research Program
44.6
44
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
Active Research Program
44.6
45
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
44.6
46
NCI Clinical
Active Research Program
44.6
47
Active Research Program
44.6
48
NCI Comprehensive
Active Research Program
44.6
4944.6
50
Active Research Program
44.6
51
Active Research Program
44.6
52
Active Research Program
44.6
53
Active Research Program
44.6
54
Active Research Program
44.6
55
NCI Comprehensive
28.5
56
NCI Comprehensive
28.5
57
NCI Comprehensive
28.5
5828.5
59
Cedars-Sinai CancerLos Angeles, CA
28.5
6028.5
6128.5
6228.5
63
Contributing Research Center
28.5
64
65
BC CancerVancouver, BC

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →